Navigation Links
Vaccinogen Completes Initial Closing of an $80 Million Financing
Date:8/25/2014

the FDA, we believe would be the first-ever patient-specific immunotherapy to prevent recurrence of colon cancer. Tussing continued, "we look forward to building on Dr. Hanna's discoveries and dedication that brought OncoVAX to this point and to working with leading cancer centers around the world to launch this important confirmatory Phase IIIb study in the coming months."

Since co-founding Vaccinogen in 2007, Mr. Tussing has overseen the financial and operational management of the company and co-led several initiatives including establishing and maintaining the Dutch cGMP manufacturing facility, leading Vaccinogen's capital raising efforts, including this financing and Vaccinogen's successful efforts to become a public company.

Financing Details

At this first closing, Vaccinogen issued units of common stock and warrants priced at $5.50 per unit consisting of 1,869,159 shares of common stock and warrants to purchase 545,454 shares of common stock at an exercise price of $6.05 per share. The remainder of the securities are issuable in a series of up to four additional closings following the achievement of additional milestones and will also be priced at $5.50 per unit or share of common stock, as applicable. The second closing of $10 million in units of common stock and warrants is expected by September 25, 2014 and is not subject to any milestones.  The last 3 closings for $60 million consist of common stock only.  TIS also has the option to invest an additional $30 million of Vaccinogen common stock under the same pricing terms as the $80 million financing until February 25, 2015, which, if exercised, would result in aggregate gross proceeds of $110 million in this financing.

For additional information on the TIS financing and related management and board reorganization, please refer to the Company's Current Reports on Form 8-K filed on April 28, 2014 and August 25, 2014 with the U.S. Securities and Exchange Commission at the
'/>"/>

SOURCE Vaccinogen, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
4. CryoLife Completes Acquisition of Hemosphere
5. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
6. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
7. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
8. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
9. Ablative Solutions Completes $5.3M Series A Financing
10. Quantum OPS Completes $1.05M In Series A Financing To Advance Surgical Devices
11. Spine Pain Management, Inc. Completes $500,000 Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... the addition of the "Market Assessment of ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... the respiratory imaging diagnostics market in ... Europe . The service provides detailed analysis ...
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth ... Electronic Health Record (EHR) is invaluable in any ... EHRs are now a requirement and mainstream in ... continuously into the EHR is gaining traction in ... William Holmes, RN, Site Project Manager & Clinical ...
(Date:5/21/2015)... & Struggles (Nasdaq: HSII ), the premier provider ... and culture shaping worldwide, strengthens its healthcare ... addition of Tim Dietlin to the firm,s ... Dietlin has extensive life sciences and professional services experience ... Commercial functions to increase productivity, drive transformational change, and ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3Heidrick Increases Healthcare and Life Sciences Expertise 2
... , ST. LOUIS , Jan. 27 ... received Section 510 (k) clearance from the U.S. Food and ... first ophthalmic device linking patients and doctors between eye exams ... a frequent but brief exam on their ForeseeHome AMD Monitor, ...
... 27 Warner Chilcott plc (Nasdaq: WCRX ... from the U.S. Food and Drug Administration (FDA) to its New ... dose" oral contraceptive (also referred to as WC 3016).   , ... substance manufacturing facility and control testing laboratory used to support the ...
Cached Medicine Technology:Notal Vision's ForeseeHome(TM) AMD Monitor Receives FDA Clearance 2FDA Issues Complete Response Letter for Low Dose Oral Contraceptive 2FDA Issues Complete Response Letter for Low Dose Oral Contraceptive 3
(Date:5/22/2015)... 2015 Memorial Day weekend is typically considered ... is offering some tips to help promote safe travel. , ... be 383 traffic fatalities this Memorial Day weekend. Amica is ... Traffic Safety Association: , , Always ... wearing a seatbelt, whether they’re driving or riding along as ...
(Date:5/22/2015)... ZH Healthcare (ZH), a ... that Bill Lane, joins ZH’s Advisory Board. ... first of its kind, Freemium SaaS, Electronic Health ... Records (EHR) with an integrated practice management system ... portal, and more. Combined with its Revenue Cycle ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Medivo, Inc., ... “Positivity Rates and Genotype Results in ‘Baby Boomers’ Screened ... from a Nationwide Lab Test Database” at Digestive Disease Week, ... Medivo’s Clinical Affairs and Analytics team members Carol Smyth, MB; ... and Andrea Parker, MSI, along with Nancy Reau, MD from ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 DMG Productions ... Jr., scheduled to broadcast on Friday, May 29, 2015 ... Discovery Channel. , In this episode Innovations will explore ... back to business quickly through disaster recovery and restoration. ... company that works collaboratively to develop and deliver training ...
(Date:5/22/2015)... In April 2006, Veatch Consulting opened for ... they have concentrated their focus to working with over ... of this growth and their goals to better serve ... Colorado, Cleveland, Ohio, Houston, Texas and now Dallas, Texas. ... offices, dental start ups, orthodontic practices, pediatric dental practices, ...
Breaking Medicine News(10 mins):Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2
... Oxford, April 5, 2012 Elsevier, a world-leading ... and services, announces the Label-Free Technologies Conference to ... 2012. Organized by Elsevier in association with ... conference entirely dedicated to bringing together the latest ...
... 2012) - Men experience a marked drop in their testosterone ... type of lung cancer. That,s according to a University of ... Cancer, the official journal of the American Cancer ... hormone levels in men with anaplastic lymphoma kinase (ALK) positive ...
... HealthDay Reporter , WEDNESDAY, April 4 (HealthDay News) ... being passed through generations, could play an important role ... Three research teams sequenced the genes of children with ... families, and compared the sequences with those of their ...
... engineers and physicians from Brigham and Women,s Hospital ... (HMS), Massachusetts Institute of Technology (MIT), BIND Biosciences, ... Karmanos Cancer Institute, and Weill Cornell Medical College ... cancer drug called BIND-014 in treating solid tumors. ...
... Simon Fraser University, has made a discovery that will change ... treated. The journal Nature has just ... and mutational evolution spectrum of primary triple negative breast cancers. ... what were thought to be triple negative breast cancer tumours. ...
... The incidence of head and neck cancers related to the ... the greatest increase among middle-aged white men, a new study ... for head and neck cancers, but the sexually transmitted infection ... to researchers from the Louisiana State University Health Sciences Center ...
Cached Medicine News:Health News:Clinical insight improves treatment with new lung cancer drug 2Health News:Clinical insight improves treatment with new lung cancer drug 3Health News:Researchers Find Gene Mutations That May Be a Key to Autism 2Health News:Researchers Find Gene Mutations That May Be a Key to Autism 3Health News:Researchers Find Gene Mutations That May Be a Key to Autism 4Health News:First targeted nanomedicine to enter human clinical studies 2Health News:First targeted nanomedicine to enter human clinical studies 3Health News:First targeted nanomedicine to enter human clinical studies 4Health News:Scientists uncover multiple faces of deadly breast cancer 2Health News:HPV-Related Head, Neck Cancers on the Rise 2
... ,Launched in 1988, this design revolutionized ... standard practice in general anesthesia. Used successfully ... Classic™ is a safe hands free alternative ... Classic™ can be used for a wide ...
... The Intubating LMA™ Airway. , ... or unexpected difficult airway, the LMA Fastrach™ ... without moving the head or neck. The ... attempts. , ,Selected by emergency teams ...
... an advancement in supralaryngeal airway management., ,The ... in the hypopharynx where it abuts the structure ... Cobra head design of the distal end of ... the epiglottis out of the way, facilitating ventilation ...
... superior, disposable supraglottic airway tool that utilizes ... design to provide the best non-intubating airway ... a safe, reliable, cost effective and efficient ... laryngoscopy is not feasible or attainable. With ...
Medicine Products: